濮阳东方线上挂号-【濮阳东方医院】,濮阳东方医院,濮阳东方医院男科看早泄很不错,濮阳东方医院男科收费咨询,濮阳东方妇科医院收费怎么样,濮阳东方医院治疗早泄好不,濮阳市东方医院坐公交路线,濮阳东方看男科靠谱吗

SAN DIEGO (KGTV) - The Food and Drug Administration is responding Friday to a Team 10 investigation launched after San Diego women complained about Monat Global hair care.Dana Sohovich talked exclusively with 10News, saying the company’s hair products caused severe hair loss and bald spots. Sohovich has filed a class action lawsuit against the company, alleging it falsely promised her “longer, fuller, stronger” hair. Her suit accuses Monat of “false and deceptive advertising”.Other women have shared pictures of scalp sores, breakage and clumps of fallen strands.RELATED: San Diego woman sues trendy hair care companyMultiple women say they went to their doctors, and there was nothing pointing to a reason, other than product use. Many consumers who complained were told it was normal and part of a detox process that was documented in the company’s own sales literature. “We no longer do that. We don’t do it,” said Monat Spokesperson Gene Grabowski during a taped phone interview.Grabowski said all the complaints don’t add up. “To have this happen in such a short period of time, statistically is impossible,” he added.At the time of Team 10's original report, about 200 adverse event reports were filed with the FDA.The FDA issued a new statement: 1265
SAN DIEGO (KGTV) -- The market may soon be looking up for San Diegans hoping to buy a home. A new report by Zillow found that many economists believe the housing market in the West will turn into a buyer’s market by 2020.According to the housing site, home-values have appreciated faster in 2018 than in 2017. That coupled with a fall in inventory means that sellers are in the driver’s seat.At least for now. Zillow says recent data suggest the balance may be starting to tilt back toward buyers. Home growth is slowing in more than half the nation’s 35 largest metros and price cuts are common.Even in San Diego, where the cost of living is well above average, 20 percent of listings saw a price cut in June.A separate report from Zillow found that the increase in home values has also slowed throughout San Diego.Three out of four economists surveyed say the national housing marked could see a shift to a buyer’s market by 2020.Those same economists say the Midwest will be the first to see the shift, beginning as early as 2019, followed by the Northeast, South and West in 2020.“For the past several years, home sellers held all the cards at the negotiating table, fielding multiple offers while buyers faced stiff competition and a fast-moving market,” said Zillow Senior Economist Aaron Terrazas.Over the next year, Zillow expects the rate of appreciation to slow to 4.7 percent in San Diego, where the median home price is 4,100.“Conditions are starting to show signs of easing up, but the effects of years of limited construction still linger. Inventory is still falling on an annual basis, and home values are growing well above their historic pace. Although these trends are starting to lose their edge, it is far too soon to call it a buyers market,” Terrazas said. 1789

SAN DIEGO (KGTV) — The first-ever professional sports event to be held on an active military base will be held in San Diego this February.As a special thank you to the military, the San Diego Seals pro lacrosse team will play a regular season game on the flight line of MCAS Miramar on Saturday, Feb. 22, 2020, against the Vancouver Warriors. The team has dubbed the first regular season pro sports game on a Marine base the "Rumble on the Runway."RELATED: Padres, D-Backs meet in regular-season games in Mexico City“With more than 100,000 active-duty military personnel calling San Diego home, we are forever grateful for their commitment to protecting our freedom, this city and this great country,” said Seals president Steve Govett. “This game, and the events surrounding it, are a way for us to say ‘thank you’ to them and their families for their service.”A special arena will be constructed to host the event and Seals players will also take part in a series of events leading up to the game with the military and their families.The event will be closed to season ticket members and select active duty, reservist, and retired military guests.RELATED: Padres players surprise San Diego elementary school students with new bikes“MCAS Miramar has a deeply rooted relationship with the San Diego community,” said Col. Charles Dockery, commanding officer, MCAS Miramar. “We strive to be outstanding neighbors to our fellow San Diegans by working hand in hand with them every chance we get. Miramar is grateful to host our San Diegan neighbors for Rumble on the Runway right here on the flight line.”Tickets will be made available to season ticket members online and are already available to military patrons. 1718
SAN DIEGO (KGTV) -- The City of San Diego says it is working to earn back the public's trust after thousands of families got hit with erroneously high water bills this year. But the problems appear to be persisting. Ed Kitrosser and his wife just got a bill for 3, more than double the usual for their home in Pacific Beach."We're on automatic sprinklers. Nothing has changed, the setting has not been changed for several years," said Kitrosser. RELATED: Inside San Diego: Audit shows City sent thousands of faulty water billsKitrosser is one of about a dozen residents in the P.B. and La Jolla area complaining about outrageously high water bills they received in September. Their concerns come after a city audit found that about 3,000 San Diegans got erroneous water bills, largely due to human error. Shawn Tobias, of La Jolla, is questioning a bill he received for more than ,800."You call the city and say 'I'm pretty sure you made a mistake on this' and they say 'no, no, this is what you used,' and then your heart drops," Tobias said. RELATED: San Diego man furious with city over ,000 water billThe city, meanwhile, says it is making progress on installing a series of reforms after the audit. That includes increased oversight on meter readers, addressing a backlog of meters that need repair, and improving communication with customers."We are now holding everyone accountable," said Johnnie Perkins, the city's deputy chief operating officer. "It's going to take some time, because this wasn't created overnight, but we're certainly going to improve it as fast as we can."The city says it is not charging late fees or turning the water off on anyone disputing a bill. RELATED: City launches app to help customers monitor water bills 1801
SAN DIEGO (KGTV) — The Department of Defense has awarded a San Diego biotech company up to million to help develop a next-generation drug to fight COVID-19.Sorrento Therapeutics calls the drug a “rapid countermeasure” against the disease, one that might serve as a vaccine substitute in certain populations or a critical stopgap tool if the virus mutates.“With this, we have a new platform potentially that can respond very quickly to any type of emerging threat,” said CEO Dr. Henry Ji.Sorrento is trying to become the first company to develop an approved DNA-encoded monoclonal antibody treatment. The approach is similar to the experimental monoclonal antibody treatment used on President Trump, but Sorrento’s concept is a more advanced version that offers several benefits.Sorrento’s drug is designed to be used as either a treatment in infected patients or a fast-forming layer of defense in healthy people. The company said its solution should be cheaper and easier to deploy than existing monoclonal antibodies, while offering vaccine-like protective effects that last for several months rather than just two or three weeks.Antibodies are one of the body’s key defense mechanisms. They seek out pathogens and bind to them, marking the invader for destruction like ground troops marking an enemy base for an airstrike. In some cases, antibodies can even neutralize an invader themselves by blocking its method of entry into cells.Monoclonal antibodies are antibodies designed by scientists to neutralize a pathogen. They are hand-picked, genetically modified super antibodies that are cloned in labs.However, the process of growing these super soldiers in the lab is difficult, transporting them requires a cold chain, and as a result, monoclonal antibodies are among the most expensive drugs in the world.Instead of giving people an infusion of pre-made antibodies, Sorrento’s idea is to give people a shot of DNA that instructs some of their cells to churn out perfectly pre-designed antibodies.“It's much easier to make enough DNA to treat a large number of people than it is to make enough protein to treat a large number of people. That’s just a fact about manufacturing,” said Dr. Robert Allen, Sorrento’s chief scientific officer on the project.Dr. Allen said the company is hopeful the drug will induce cells to make protective antibodies for six months or more.This DNA approach to an antibody treatment has never been approved for any disease but other companies are working on their own versions of it. Another biotech with ties to San Diego, Inovio Pharmaceuticals, became the first company to test this approach in humans in 2019 for a drug targeting the Zika virus.Sorrento’s approach is similar to the way DNA vaccines work, but it cuts out intermediary steps and jumpstarts the production of antibodies, rather than leaving the production of antibodies up to the body’s immune system. The result is that protective antibodies can start circulating in days after injection rather than weeks, the company said.“What this is capable of doing is it bypasses the need for the immune system,” said Dr. Mark Brunswick, Sorrento’s senior vice president for regulatory affairs.The drug is unlikely to replace a vaccine in most situations because vaccines can produce other defense mechanisms like T-cells that work in conjunction with antibodies. But the drug might work better than a vaccine for the elderly and others with weakened immune systems who are unable to produce a robust number of antibodies on their own, Brunswick said.Still, the company still has a lot of pre-clinical work and testing to go. Sorrento is hoping to have the drug ready for human trials in four to six months.By then, vaccines from Pfizer and Moderna will likely be widely available, but Dr. Ji said the world needs to prepare for the possibility this virus will mutate.“When you vaccinate hundreds of millions, potentially billions of people, the virus is under tremendous evolution pressure,” he said. “It will escape. It’s guaranteed that the virus is going to mutate and escape all of the vaccines we’re trying to create.”If it does, he said Sorrento will be ready to rapidly deploy its DNA-based countermeasure. 4223
来源:资阳报